• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


0.778 EUR 0.002 0.26%

As of 02:04:43 ET on 01/26/2015.

Snapshot for Durect Corp (DC8)

Open: 0.778 Day's Range: 0.778 - 0.778 Volume: 0
Previous Close: 0.776 52wk Range: 0.531 - 1.647 1-Yr Rtn: -48.88%

Stock Chart for DC8

No chart data available.
  • DC8:GR 0.778
  • 1M
  • 1Y
Interactive DC8 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DC8

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.1950
Est. PEG Ratio -
Market Cap (M EUR) 88.44
Shares Outstanding (M) 113.68
30 Day Average Volume 2
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DC8

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DC8

Durect Corporation develops and commercializes pharmaceutical systems for the treatment of chronic diseases. The pharmaceutical systems provide therapy for chronic diseases or conditions by replacing multiple injection therapy or oral dosing, improving drug efficacy, reducing side effects, and ensuring dosing compliance.

Felix TheeuwesChairman/Chief Scientific OfcrJames E BrownPresident/CEO/Co-Founder
Matthew J HoganChief Financial OfficerSu Il YumExec VP:Pharmaceutical Sys
More Company Profile & Key Executives for DC8

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil